Search Login Register

Neuraminidase (Sialidase) Summary

Description: An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)

Also Known As: Sialidase; Exo-alpha-Sialidase; N-Acylneuraminate Glycohydrolases; Oligosaccharide Sialidase; Exo alpha Sialidase Show All >>

Networked: 3440 relevant articles (177 outcomes, 280 trials/studies) for this Bio-Agent

Key Diseases for which Neuraminidase is Relevant

  1. Human Influenza (Influenza) : 106 outcomes 164 studies in 1714 results
  2. Infection : 69 outcomes 31 studies in 632 results
  3. Neoplasms (Cancer) : 8 outcomes 13 studies in 227 results
  4. Influenza in Birds (Avian Flu) : 7 outcomes 25 studies in 232 results
  5. Pneumonia (Pneumonitis) : 4 outcomes 3 studies in 23 results
Show All >>

Drugs Related to Neuraminidase

  1. Oseltamivir (Tamiflu)
  2. Zanamivir (Relenza)
  3. Hemagglutinins (Hemagglutinin)
  4. Antiviral Agents (Antivirals)
  5. Antibodies
  6. peramivir
  7. N-Acetylneuraminic Acid (Sialic Acid)
  8. Vaccines
  9. Amantadine (Aman)
  10. Rimantadine
Show All >>

Therapies Related to Neuraminidase

  1. Chemoprevention
  2. Drug Therapy (Chemotherapy)
  3. Long-Term Care
  4. Home Nursing (Nursing, Home)
  5. Mucosal Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.